MSK-Cornell Center for Translation of Cancer Nanomedicine
From Nanomaterials to Cancer Patient Care
The MSK-Cornell Center for Translation of Cancer Nanomedicine is a multi-institutional, multi-disciplinary CCNE brought together to advance, translate, and disseminate a suite of ultrasmall multimodal fluorescent core-shell silica nanoparticles with tunable size, brightness, and geometry, referred to as Cornell dots or C dots, with the goal of dramatically impacting clinical cancer care. The MSK-Cornell Center for Translation of Cancer Nanomedicine was created around a collaboration between Cornell on the Ithaca Campus, NY, and Memorial Sloan Kettering in NYC. Also part of this Center is a start-up company, Elucida Technologies, Inc., that is bringing the particle platform studied in the Center to the market to improve cancer patient care.